New Pediatric Hematology-Oncology Specialist to Join Hospital
Dr. Degliuomini’s clinical and research focus is on the effects of children’s cancer treatment on platelets
Hackensack Meridian Children’s Health is proud to welcome pediatric hematology-oncology specialist Melanie Degliuomini, M.D., MS, to the pediatric cancer program at Joseph M. Sanzari Children’s Hospital at Hackensack University Medical Center. Dr. Degliuomini joins 16 other hematology-oncology specialists on the Hackensack Meridian Children’s Health pediatric oncology team.
Board-certified in pediatrics, Dr. Degliuomini treats solid tumors, blood cancers and other blood disorders in children. She has a special clinical and research interest in chemotherapy-induced thrombocytopenia (CIT), a complication of chemotherapy that causes a low platelet count, in children with blood cancers and solid tumors.
Dr. Degliuomini earned her medical degree and her master’s degree at Drexel University College of Medicine in Philadelphia, PA. She then completed her pediatrics residency at New York Presbyterian (NYP)/Weill Cornell Medicine, followed by a pediatric hematology-oncology fellowship in a combined program through Memorial Sloan Kettering Cancer Center (MSK) and NYPWeill Cornell Medicine in New York, New York. She also earned her Master’s in Clinical and Translational Investigation at Weill Cornell Medicine.
“I provide comprehensive care for children who are diagnosed with blood cancers and solid tumors,” said Dr. Degliuomini. “Through my research, I hope to improve the hematology- oncology community’s understanding of CIT and how it affects children receiving cancer treatment, with the goal of reducing the need for platelet transfusion and preventing delays in critical cancer care delivery.”
Learn more about our advancements in pediatric oncology at Hackensack Meridian Children’s Health.